Vitamin D deficiency is widely prevalent across all ages, races, geographical regions, and
socioeconomic strata. In addition to its important role in skeletal development and calcium …

Aims Primary hyperparathyroidism (PHPT), one of the most frequent endocrine disorders, is
not only associated with bone and kidney disorders but also with increased cardiovascular …

Objective: The authors sought to compare the incidence of adverse cardiovascular (CV)
events in older adults with primary hyperparathyroidism (PHPT) treated with …

Objective High circulating concentrations of parathyroid hormone (PTH) have been
associated with increased risks of hypertension, left ventricular hypertrophy, congestive …

OBJECTIVE: To conduct a literature review on the diagnosis and management of primary
hyperparathyroidism including the classical hipercalcemic form as well as the …

Objective—Cardiovascular risk factors have different impact on different arterial territories.
Diseases with elevated circulating parathyroid hormone (PTH) such as primary …

Vitamin D deficiency contributes to cardiovascular risk (CVR), with hyperparathyroidism
advocated as a putative mechanism. Indeed, mounting evidence supports the hypothesis …

We performed a randomized controlled trial in 30 HIV-infected participants to either continue
tenofovir/emtricitabine/efavirenz (Continuation Group) or switch to tenofovir/emtricitabine …

Primary hyperparathyroidism (PHPT) is the third most common endocrinopathy seen today,
and is most frequently found in the 6th to 7th decade of life. PHPT can present with various …

Objective Changes in endothelial function, measured as flow-mediated dilation (FMD) of the
brachial artery, has not been systematically assessed beyond 6 months of initiation of …